Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 22 in 2017. The prevalence of Polio disease is key driver to lead to growth of polio vaccines market. mainly affects children under 5 years of age. Up to 70% of all the infections in children are without any symptoms and about 25-30% of infections in children causes? nonspecific illness without clinical or laboratory evidence of central nervous system invasion. This has created a gesture for the organizations to focus on the vaccines options for making prophylactic approach towards the prevention of the disorder, which in turn is expected to fuel the polio vaccines market in the near future. As far as the geography is concerned, North American is currently leading the market, the reason being initiatives laid down by the government for encouraging the adoption of immunization against diseases like influenza and HPV. The global Polio Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Polio Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polio Vaccines market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polio Vaccines in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Polio Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. The following manufacturers are covered: CSL GlaxoSmithKline Johnson & Johnson MedImmune Merck Pfizer Sanofi Pasteur Serum Institute Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type IPV OPV Segment by Application Age (0-1) Age Above 1
Table of Contents Executive Summary 1 Industry Overview of Polio Vaccines 1.1 Definition of Polio Vaccines 1.2 Polio Vaccines Segment by Type 1.2.1 Global Polio Vaccines Production Growth Rate Comparison by Types (2014-2025) 1.2.2 IPV 1.2.3 OPV 1.3 Polio Vaccines Segment by Applications 1.3.1 Global Polio Vaccines Consumption Comparison by App
